Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

October 15, 2019

Study Completion Date

October 15, 2019

Conditions
Acute Unilateral Vestibulopathy (AUV)
Interventions
DRUG

SENS-111 100mg

SENS-111 100mg is presented as 1 Oral Dispersible Tablet of SENS-111 100mg + 1 Oral Dispersible Tablet of placebo given twice on Day 1, second intake given approximately 12 hours (9 to 15 hours) after the first intake and thereafter given once daily on Days 2 to 5 inclusive. The corresponding total dose will be 500 mg for the entire study.

DRUG

SENS-111 200mg

SENS-111 200mg is presented as 2 Oral Dispersible Tablet of SENS-111 100mg given twice on Day 1,second intake given approximately 12 hours (9 to 15 hours) after the first intake and thereafter given once daily on Days 2 to 5 inclusive. The corresponding total dose will be 1000 mg for the entire study.

DRUG

Placebo Oral Tablet

Placebo is presented as 2 Oral Dispersible Tablets of placebo given twice on Day 1, second intake given approximately 12 hours (9 to 15 hours) after the first intake and thereafter given once daily on Days 2 to 5 inclusive. The corresponding total dose will be 0 mg for the entire study.

Trial Locations (24)

1106

Bajcsy-Zsilinszky Kórház és Rendelőintézet, Budapest

6725

Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Szeged

7621

Pécsi Tudományegyetem, ÁOK Klinikai Központ, Pécs

10032

Columbia University Medical Center, New York

12683

Klinikum Unfallkrankenhaus Berlin, Berlin

13620

Seoul National University Bundang Hospital, Gyeonggi-do

20132

Ospedale San Raffaele IRCCS, Milan

23538

Universitätsklinikum Schleswig-Holstein Ratzeburger, Lübeck

34295

CHU Gui de Chauliac, Montpellier

35015

Chungnam National University Hospital, Junggu

38100

Hillel Yaffe Medical Center, Hadera

50005

University Hospital Hradec Králové, Hradec Králové

61469

Chonnam National University Hospital, Donggu

75010

Hôpital Lariboisière, Paris

81377

Klinikum der Universität München, Munich

84101

Soroka Medical Center, Beersheba

84503

Kreiskliniken Altötting, Altötting

3109601

Rambam Health Care Campus, Haifa

3436212

Carmel Medical Center, Haifa

4428164

Meir Medical Center, Kfar Saba

4941492

Rabin Medical Center, Petah Tikva

02559

St. Paul's Hospital, The Catholic University of Korea, Seoul

05505

Asan Medical Center, Seoul

06273

Gangnam Severance Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sensorion

INDUSTRY

NCT03110458 - Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy | Biotech Hunter | Biotech Hunter